Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

2021-02-18 21:00 5052

United Imaging Announces Agreement with Vizient for Computed Tomography Systems.

HOUSTON, Feb. 18, 2021 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced an agreement to offer its suite of cutting-edge Computed Tomography technology to Vizient members at contracted pricing. For maximum clinical flexibility, all ...

2021-02-18 21:00 1659

Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club

SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) reported preliminary financial results for the fourth quarter and the fiscal year of 2020, showing records never seen before. The company postedKRW 441.7 billion in consolidat...

2021-02-18 15:00 7412

Everest Medicines Appoints Kevin Guo as Chief Commercial Officer

SHANGHAI, Feb. 18, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-02-18 12:26 5743

Everest Medicines Appoints Kevin Guo as Chief Commercial Officer

2021-02-18 12:21 2953

First Cancer Early Screening Company Listed on HKEX as New Horizon Health Debuts

SHANGHAI, Feb. 18, 2021 /PRNewswire/ -- Qiming's portfolio company New Horizon Health (SEHK:6606) officially listed on the Main Board of Hong Kong Stock Exchange (HKEx) today. This is the first listed Chinese cancer early screening company. The issue price is HK$26.66 per share; the stock open...

2021-02-18 12:11 6042

Seegene's saliva test for COVID-19 is just as effective as NPS test

SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine,...

2021-02-18 11:43 1741

Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration to Develop and Commercialize Rivastigmine Multi-Day Transdermal Patch in Japan

BASEL, Switzerland, Feb. 18, 2021 /PRNewswire/ -- Luye Pharma Group announced that its subsidiary Luye Pharma Switzerland AG has entered into an agreement with Towa Pharmaceutical Co., Ltd. (Towa), the terms of which grant Towa exclusive rights to the development and commercialization of Rivastig...

2021-02-18 11:24 2985

Indian Students Thrive Internationally with Offshore Medical Universities in St Kitts and Nevis

LONDON, Feb. 18, 2021 /PRNewswire/ -- The Federation of St Kitts and Nevis is one of the most beautiful and lively countries on the planet. However, the tropical islands' rainforests and diverse wildlife are not the only things that make it so desirable. Thousands of doctors worldwide have gotten...

2021-02-18 08:00 2388

Vax-Immune Diagnostics Takes Innovative Women's Health Diagnostic Device to European Markets to Improve Maternal Group B Strep Testing Processes

HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Vax-Immune Diagnostics announces today it has received CE Mark approval for its first-in-class medical device, LabReady® GBS.LabReady's Group B Strep product is the first in Vax-Immune Diagnostics' lineup of women's health solutions that helps avoid life-th...

2021-02-18 01:03 1492

EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)

PROVIDENCE, R.I., Feb. 18, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU,India, and United States (funded by the EU and India) with the aim of develop...

2021-02-18 01:01 1912

Frost & Sullivan Examines Virtual Critical Care Solutions for Application in the US and EU-5 by 2025

Proof of concept set in place by leading solutions providers and flexibility provided by software/web-enabled platforms benefit users of predictive, protocol and surveillance-based solutions SANTA CLARA, Calif., Feb. 18, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the outb...

2021-02-18 00:50 1818

New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in Children

National Comprehensive Cancer Network publishes first-ever complete medical guidelines for a pediatric solid tumor, so children everywhere receive the best care based on the latest research. NCCN Guidelines for Wilms Tumor shares information for earlier, safer diagnosis and treatment in effort t...

2021-02-17 21:35 1603

New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in Children

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

2021-02-17 20:00 3320

Joint feasibility assessment of Bionomics' BNC210 and EmpathBio's MDMA derivative EMP-01 treatment regimen for PTSD

ADELAIDE, Australia, Feb. 17, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB: BNOEF,Germany: AU000000BNO5) (Bionomics) today announced that it has entered into a Memorandum of Understanding with EmpathBio Inc (EmpathBio), a wholly owned subsidiary ofGermany-based CNS clinical development...

2021-02-17 19:00 5753

Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research

Timely presentations of trial data will accelerate transition from research to practice LUGANO, Switzerland, Feb. 17, 2021 /PRNewswire/ -- ESMO, the leading organisation for medical oncology, launches an important new service for rapidly disseminating research to accelerate the transition of res...

2021-02-17 13:00 1396

Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy

LAUSANNE, Switzerland, Feb. 17, 2021 /PRNewswire/ -- Onward Therapeutics SA (Onward) announced today the execution of a strategic investment in EMERCell SAS, Montpellier,France, a company that has developed a platform technology to produce off-the-shelf natural killer (NK) cells. The undisclosed ...

2021-02-17 13:00 1389

ABG Acquisition Corp. I Announces Pricing of Upsized $131 Million Initial Public Offering

NEW YORK and HONG KONG, Feb. 17, 2021 /PRNewswire/ -- ABG Acquisition Corp. I (the "Company") today announced the pricing of its initial public offering of 13,100,000 Class A ordinary shares at a price of$10.00 per share. The shares will be listed on The Nasdaq Capital Market and trade under the ...

2021-02-17 11:59 2195

Indian conglomerate, Godrej & Boyce aims to strengthen Vaccine Cold Chain across the world

Cold Chain Partner to the world's largest covid vaccination drive in India, refrigeration expert Godrej & Boyce launches 'made inIndia' ultra-low-temperature freezers (below -80°C) Offers vaccine cold chain solutions across all temperature bands MUMBAI, India, Feb. 17, 2021 /PRNewswire/ -- Godr...

2021-02-17 11:00 3146

88% Vaccination Rate Across Yas Island Employees

Abu Dhabi's leading leisure and entertainment destination to be among the first in the world to vaccinate most of itsemployees, signaling its commitment to health and safety ABU DHABI, UAE, Feb. 17, 2021 /PRNewswire/ -- Eighty-eight per cent employees working at attractions, experiences, hotels,...

2021-02-17 09:00 645

88% Vaccination Rate Across Yas Island Employees

1 ... 552 553 554555556 557 558 ... 807